Dendrimer a versatile polymer in drug delivery

被引:7
作者
Singh, Shakti K. [1 ]
Lohiya, G. K. [1 ]
Limburkar, P. P. [1 ]
Dharbale, N. B. [1 ]
Mourya, V. K. [1 ]
机构
[1] Govt Coll Pharm, Opp Govt, Dept Pharmaceut, Polytech, Aurangabad, Maharashtra, India
关键词
Biomaterials; dendrimer; drug delivery; nanoscopic drug carriers; polyamidoamine (PAMAM) dendrimer;
D O I
10.4103/0973-8398.56295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dendrimers are a unique class of synthetic macromolecules having highly branched, three-dimensional, nanoscale architecture with very low polydispersity and high functionality. Structural advantages allow dendrimers to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry. This review discusses several aspects of dendrimers, including preparation, dendrimer-drug coupling chemistry, structural models of dendrimer-based drug delivery systems, and physicochemical and toxicological properties. Dendrimers have emerged as one of the most interesting themes for researchers as a result of their unique architecture and macromolecular characteristics. Several groups are involved in exploring their potential as versatile carriers in drug delivery. The use of dendrimers in drug delivery has been reviewed extensively. The increasing relevance of the potential of dendrimers in drug delivery emphasizes the need to explore the routes by which they can be administered. The high level of control possible over the architectural design of dendrimers; their size, shape, branching length/density, and their surface functionality clearly distinguish these structures as unique and optimum carriers in those applications. The bioactive agents may be encapsulated into the interior of the dendrimers or chemically attached/physically adsorbed onto the dendrimer surface, with the option of tailoring the carrier to the specific needs of the active material and its therapeutic applications. This review clearly demonstrates the potential of this new fourth major class of polymer architecture and indeed substantiates the high hopes for the future of dendrimers.
引用
收藏
页码:178 / 187
页数:10
相关论文
共 59 条
  • [1] ACHAR S, 1994, ANGEW CHEM INT EDIT, V33, P847, DOI 10.1002/anie.199408471
  • [2] Asthana A, 2005, AAPS PHARMSCITECH, V13, P200
  • [3] Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives
    Beezer, AE
    King, ASH
    Martin, IK
    Mitchell, JC
    Twyman, LJ
    Wain, CF
    [J]. TETRAHEDRON, 2003, 59 (22) : 3873 - 3880
  • [4] Bezouska Karel, 2002, J Biotechnol, V90, P269
  • [5] A PEGylated dendritic nanoparticulate carrier of fluorouracil
    Bhadra, D
    Bhadra, S
    Jain, S
    Jain, NK
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 257 (1-2) : 111 - 124
  • [6] DNA complexing with polyamidoamine dendrimers: Implications for transfection
    Bielinska, AU
    Chen, CL
    Johnson, J
    Baker, JR
    [J]. BIOCONJUGATE CHEMISTRY, 1999, 10 (05) : 843 - 850
  • [7] Five generations of nitroxyl-functionalized dendrimers
    Bosman, AW
    Janssen, RAJ
    Miejer, EW
    [J]. MACROMOLECULES, 1997, 30 (12) : 3606 - 3611
  • [8] Slab-gel and capillary electrophoretic characterization of polyamidoamine dendrimers
    Brothers, HM
    Piehler, LT
    Tomalia, DA
    [J]. JOURNAL OF CHROMATOGRAPHY A, 1998, 814 (1-2) : 233 - 246
  • [9] Characterization of dendrimers
    Caminade, AM
    Laurent, R
    Majoral, JP
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (15) : 2130 - 2146
  • [10] Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin
    Chauhan, AS
    Sridevi, S
    Chalasani, KB
    Jain, AK
    Jain, SK
    Jain, NK
    Diwan, PV
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 90 (03) : 335 - 343